Hello! Thank you for looking at my profile.I'm Chrysovalantis Voutouris, and I'm deeply passionate about revolutionizing healthcare through AI and deep learning. I firmly believe that cutting-edge technology can not only enhance healthcare quality but also save lives and improve patient outcomes.In today's complex healthcare landscape, AI and deep learning offer innovative solutions. I'm inspired by their potential to drive progress in medical diagnosis, treatment planning, drug discovery, and patient care, making healthcare more personalized, precise, and accessible worldwide.My background in engineering, coupled with AI expertise, drives me to develop novel solutions for critical healthcare challenges. By leveraging AI algorithms and deep learning models, I aim to empower healthcare professionals with actionable insights, enable early disease detection, and optimize treatments, all contributing to a healthier global community.I'm committed to fostering interdisciplinary collaborations between technologists, clinicians, and researchers, unlocking AI and deep learning's full potential in healthcare, ushering in a new era of medical innovation.I received a Diploma (Bachelor of Mechanical Engineering) from the Department of Mechanical and Manufacturing Engineering at the University of Cyprus in 2013. The same year, I joined the Department’s graduate program, where I focused on modeling the mechanical response of solid tumors. After completing my PhD in February 2018, I continued my academic journey as a Post-doctoral Fellow at the Cancer Biophysics Laboratory within the Department of Mechanical and Manufacturing Engineering at the Faculty of Engineering, University of Cyprus.At the present stage, I am as the CEO and Founder of AnaBioSi-Data Ltd, a pioneering venture at the intersection of healthcare and technology. In addition to my role at AnaBioSi-Data Ltd, I also hold the prestigious position of a Marie Skłodowska-Curie Post-doctoral fellow and serve as a Principal Investigator at the Radiation Oncology department, Harvard Medical School/Massachusetts General Hospital, USA, as well as continuing my involvement with the Cancer Biophysics Lab at the University of Cyprus.